Free shipping on all orders over $ 500

 About 6 results found for searched term "LK-44" (0.127 seconds)

Cat.No.  Name Target
M24696 Ascrinvacumab ALK
Anti-ACVRL1/ALK-1 Reference Antibody; PF-03446962
Ascrinvacumab (PF-03446962) is a human IgG2 monoclonal antibody targets ALK-1. Ascrinvacumab shows binding efficiency with human ALK1 with a Kd value of 7 nM. Ascrinvacumab can be used for the research of hepatocellular carcinoma (HCC).
M42988 LK-44 Others
hCES2A-IN-2 is an orally active human carboxylesterase 2 (hCES2A) inhibitor (IC50: 5.02 μM).
M55680 Recombinant Human PSA/KLK3 Protein (HEK293, 244AA, C-6His) Cytokines and Growth Factors
Prostate-Specific Antigen; Seminin; Kallikrein-3; P-30 Antigen
Recombinant Human PSA/KLK3 is a member of serine proteases having diverse physiological functions. Kallikreins are implicated in carcinogenesis and some have potential as novel cancer and other disease biomarkers. Its encoded protein is secreted and may play a role in suppression of tumorigenesis in breast and prostate cancers.
M4240 Shikonin TNF Receptor
C.I. 75535; Isoarnebin 4; CAS# 54952-43-1
Shikonin (C.I. 75535, Anchusin, Anchusa acid, Alkanna Red, Isoarnebin 4, NSC 252844) is an effective and specific inhibitor of Pyruvate kinase M2 (PKM2). Shikonin is the main ingredient of Lithosia, a Chinese herb with a variety of biological activities. Shikonin acts as an anti-inflammatory by inhibiting tumor necrosis factor-α (TNF-α), Proteasome can inhibit the activation of nuclear factor-κB (NF-κB) signaling pathway.
M8071 PF-6422899 Others
PF-6422899 is an alkynylated derivative of PF-6274484; irreversible inhibitor of EGFR kinase activity.
M29632 M4K2234  ALK
M4K2234 (compound 26b) is an ALK2 inhibitor. M4K2234 inhibits ALK2 and ALK5 with IC50s of 5 and 2144 nM, respectively. M4K2234 can be used as a chemical probe for ALK1 and ALK2 protein kinases. M4K2234 can be used for the research of cancer.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.